Stockscreener 앱 받기
1.19
4.03%
-0.05
시간 외 거래:
1.14
-0.05
-4.20%
전일 마감가:
$1.24
열려 있는:
$1.2
하루 거래량:
1.71M
Relative Volume:
1.28
시가총액:
$454.57M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.2526
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
-6.30%
1개월 성능:
-11.19%
6개월 성능:
-0.83%
1년 성능:
-43.33%
1일 변동 폭
$1.16
$1.22
1주일 범위
$1.12
$1.27
52주 변동 폭
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.19 | 473.67M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools: Q3 Earnings Snapshot - News-Times
Standard BioTools Reports Third Quarter 2025 Financial Results - Investing News Network
Standard BioTools Q3 revenue falls - MarketScreener
Standard BioTools Inc (LAB) Q3 2025 Earnings: Revenue Surpasses Estimates at $19.6M, EPS Misses with -$0.08 - GuruFocus
Standard BioTools Implements Restructuring for Future Growth - TipRanks
Why analysts raise outlook for Standard BioTools Inc. (FLB) stockJuly 2025 Institutional & Verified Short-Term Plans - newser.com
Will Standard BioTools Inc. outperform the marketGold Moves & Real-Time Price Movement Reports - newser.com
Why Standard BioTools Inc. (FLB) stock is upgraded to buyDollar Strength & Community Driven Trade Alerts - newser.com
Understanding Standard BioTools Inc.’s price movementBull Run & Free Weekly Watchlist of Top Performers - newser.com
Earnings To Watch: Standard BioTools Inc (LAB) Reports Q3 2025 R - GuruFocus
Earnings To Watch: Standard BioTools Inc (LAB) Reports Q3 2025 Result - Yahoo Finance
How Standard BioTools Inc. stock performs in interest rate cyclesQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Why Standard BioTools Inc. (FLB) stock gets analyst attention2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Can momentum traders help lift Standard BioTools Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Analyzing net buyer seller activity in Standard BioTools Inc.July 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
Top chart patterns to watch in Standard BioTools Inc.Buy Signal & Low Drawdown Trading Strategies - newser.com
Standard BioTools Inc. recovery potential after sell off2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Is Mahasagar Travels Limited Stock a Core Holding or a Speculative PlayCup and Handle Formations & Technical + Fundamental = Smarter Investing - earlytimes.in
Is Standard BioTools Inc. stock cheap compared to fundamentalsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Standard BioTools' (LAB) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.23%
자본화:
|
볼륨(24시간):